_1000.jpg)
Publications
This is a selection of our publications. Follow this link for a full overview on PubMed.
2022
Improving Infinium MethylationEPIC data processing: re-annotation of enhancers and long noncoding RNA genes and benchmarking of normalization methods
Martin Bizet, Matthieu Defrance, Emilie Calonne, Gianluca Bontempi, Christos Sotiriou, François Fuks, Jana Jeschke
Epigenetics
Why novel mRNA modifications are so challenging and what we can do about it
Audrey Penning, Jana Jeschke, François Fuks
Nature Reviews Molecular Cell Biology
2021
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors
Jana Jeschke, Evelyne Collignon, Clémence Al Wardi, Mohammad Krayem, et al.
Nature Cancer
2019
MEXPRESS update 2019
Alexander Koch, Jana Jeschke, Wim Van Criekinge, Manon van Engeland, Tim De Meyer
Nucleic Acids Research
DOI: 10.1093/nar/gkz445
2017
DNA methylation-based immune response signature improves patient diagnosis in multiple cancers
Jana Jeschke, Martin Bizet, et al.
Journal of Clinical Investigation
DOI: 10.1172/JCI91095
2016
Portraits of TET-mediated DNA hydroxymethylation in cancer
Jana Jeschke, Evelyne Collignon, François Fuks
Current Opinion in Genetics & Development
2015
MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data
Alexander Koch, Tim De Meyer, Jana Jeschke, Wim Van Criekinge
BMC Genomics
DNA methylome profiling beyond promoters - taking an epigenetic snapshot of the breast tumor microenvironment
Jana Jeschke, Evelyne Collignon, François Fuks
FEBS Journal
DOI: 10.1111/febs.13125
2013
Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines
Jana Jeschke, Heather M O'Hagan, Wei Zhang, et al.
Clinical Cancer Research